BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 6889309)

  • 21. [Prospects of the use of cyclosporin A in rheumatic diseases].
    Nasonov EL; Shtutman VZ; Nasonova VA
    Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lupus erythematosus. 4. Investigation of the oral cavity: a) The antibody picture in studies of oral lesions, b) Immunopathology, c) S.L.E. and Sjogren syndrome; d) L.E. and collagen disease, e) The importance of oral lesions in L.E].
    Frojo M; Palomba F; Rullo R
    Arch Stomatol (Napoli); 1989 Nov; 30(5):999-1027. PubMed ID: 2701789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The autoimmune diseases.
    Condemi JJ
    JAMA; 1992 Nov; 268(20):2882-92. PubMed ID: 1433704
    [No Abstract]   [Full Text] [Related]  

  • 24. The occurrence of immunoglobulins in the dermo-epidermal junction of the skin in lupus erythematosus and related syndromes.
    Kalsbeek GL; Cormane RH
    Dermatologica; 1967; 135(2):205-15. PubMed ID: 4167752
    [No Abstract]   [Full Text] [Related]  

  • 25. Faulty immune systems--a cause of oral disease.
    Mohammad AR
    Middle East Dent Oral Health; 1985; (4):29-31. PubMed ID: 3865046
    [No Abstract]   [Full Text] [Related]  

  • 26. Viruses and autoimmune disease.
    Vaughan JH
    J Rheumatol; 1996 Nov; 23(11):1831-3. PubMed ID: 8923350
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune interferon in the circulation of patients with autoimmune disease.
    Hooks JJ; Moutsopoulos HM; Geis SA; Stahl NI; Decker JL; Notkins AL
    N Engl J Med; 1979 Jul; 301(1):5-8. PubMed ID: 449915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consideration of pathogenesis of rheumatoid arthritis as collagen autoimmunity.
    Steffen C
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Apr; 139(3):219-27. PubMed ID: 4250050
    [No Abstract]   [Full Text] [Related]  

  • 29. [The electron of antibodies fixed in vivo the skin level in pemphigus, bullous pemphigoid and lupus erythematosus].
    Thivolet J; Beyvin AJ; Le Mot J
    Lyon Med; 1972 Feb; 227(3):241-5. PubMed ID: 5037158
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibodies to viral and synthetic double-stranded RNA in discoid lupus erythematosus.
    Sylvester RA; Attias M; Talal N; Tuffanelli DL
    Arthritis Rheum; 1973; 16(3):383-7. PubMed ID: 4350627
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostic importance of immunofluorescence in oral bullous diseases and lupus erythematosus.
    Nisengard RJ; Jablonska S; Beutner EH; Shu S; Chorzelski TP; Jarzabek M; Blaszczyk M; Rzesa G
    Oral Surg Oral Med Oral Pathol; 1975 Sep; 40(3):365-75. PubMed ID: 1101128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of tubuloreticular structures in circulating lymphocytes of patients with erythematodes].
    Horváth A; Schaff Z; Kramer M; Szepesházi K; Ablonczy E; Bognár A; Király K; Lapis K
    Orv Hetil; 1977 Feb; 118(9):500-3. PubMed ID: 840483
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence for possible retroviral involvement in autoimmune diseases.
    Talal N; Flescher E; Dang H
    Ann Allergy; 1992 Sep; 69(3):221-4. PubMed ID: 1326239
    [No Abstract]   [Full Text] [Related]  

  • 36. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
    Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
    Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune diseases in China.
    Li R; Sun X; Liu X; Yang Y; Li Z
    Adv Immunol; 2019; 144():173-216. PubMed ID: 31699217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum complement levels in systemic lupus erythematosus].
    Morita M; Nishishita S; Amano T; Ofuji T
    Arerugi; 1971 Mar; 20(3):159-68. PubMed ID: 4101817
    [No Abstract]   [Full Text] [Related]  

  • 39. Autoantibodies and the autoimmune diseases.
    Josephson AS
    Bull N Y Acad Med; 1981 Sep; 57(7):631-7. PubMed ID: 6974027
    [No Abstract]   [Full Text] [Related]  

  • 40. CD5 B cells in autoimmunity.
    Talal N; Dauphinee M; Ahmed SA
    Ann N Y Acad Sci; 1992 May; 651():551-6. PubMed ID: 1376075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.